Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

Abstract Introduction The safety of tofacitinib in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) has been demonstrated in clinical studies of ≤ 4 and 9.5 years, respectively. Post-marketing surveillance (PMS) data for tofacitinib from spontaneous and voluntary adverse event (AE) reports ha...

书目详细资料
Main Authors:	Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
格式:	文件
语言:	English
出版:	Adis, Springer Healthcare 2023-07-01
丛编:	Rheumatology and Therapy
主题:	Post-marketing surveillance Psoriatic arthritis Rheumatoid arthritis Safety Tofacitinib
在线阅读:	https://doi.org/10.1007/s40744-023-00576-8

相似书籍

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
由: Philip J. Mease, et al.
出版: (2024-01-01)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
由: Lars Erik Kristensen, et al.
出版: (2024-05-01)

Psoriatic arthritis - Tofacitinib as a new treatment
由: Marta Skorupska, et al.
出版: (2024-06-01)

Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients
由: E. E. Gubar, et al.
出版: (2021-05-01)

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
由: Kevin L. Winthrop, et al.
出版: (2022-12-01)

Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
由: Peter Nash, et al.
出版: (2020-06-01)

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
由: Peter C. Taylor, et al.
出版: (2022-07-01)

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
由: Peter Nash, et al.
出版: (2018-11-01)

EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
由: E. Yu. Loginova, et al.
出版: (2020-06-01)

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis
由: Dafna D. Gladman, et al.
出版: (2024-12-01)

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
由: Philip J. Mease, et al.
出版: (2023-08-01)

Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies
由: Ana-Maria Orbai, et al.
出版: (2022-09-01)

Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice
由: L. D. Vorobyeva, et al.
出版: (2022-07-01)

Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
由: Gerd R. Burmester, et al.
出版: (2023-12-01)

A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents
由: Andrea Picchianti Diamanti, et al.
出版: (2024-11-01)

Efficacy of tofacitinib on rheumatoid arthritis: A retrospective single-center cohort study
由: Yuhui Qi, et al.
出版: (2023-09-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
由: Sh. F. Erdes
出版: (2014-12-01)

Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis
由: Samantha Sarabia, et al.
出版: (2022-09-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
由: E. L. Nasonov
出版: (2014-06-01)

Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis
由: E. Yu. Loginova, et al.
出版: (2024-10-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
由: E. E. Gubar, et al.
出版: (2021-10-01)

Cardiovascular risk factors in psoriatic and rheumatoid arthritis
由: Andrey Petrovich Rebrov, et al.
出版: (2011-05-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
由: Alexis Ogdie, et al.
出版: (2024-09-01)

Clinical and instrumental characteristics of axial psoriatic arthritis in combination with hyperuricemia
由: Yu. L. Korsakova, et al.
出版: (2024-08-01)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
由: Paola Di Benedetto, et al.
出版: (2021-08-01)

THE PLACE OF TOFACITINIB IN THE TREATMENT STRATEGY OF RHEUMATOID ARTHRITIS
由: V. I. Mazurov, et al.
出版: (2018-05-01)

Psoriatic arthritis: imaging techniques
由: E. Lubrano, et al.
出版: (2012-06-01)

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
由: Dafna D. Gladman, MD, et al.
出版: (2020-01-01)

CLINICAL HETEROGENEITY OF EARLY PSORIATIC ARTHRITIS
由: V. V. Badokin, et al.
出版: (2016-12-01)

Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
由: Elena V. Bogdanova
出版: (2023-01-01)

Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort
由: Chanakya Kodishala, et al.
出版: (2022-01-01)

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
由: Chimenti MS, et al.
出版: (2020-08-01)

Updated international recommendations (EULAR, 2023) for the treatment of psoriatic arthritis
由: Yu. L. Korsakova, et al.
出版: (2024-11-01)

Methotrexate in a psoriatic arthritis patient
由: K. V. Aleksanyan, et al.
出版: (2022-12-01)

Enthesitis in psoriatic arthritis
由: Mihaela Agache, et al.
出版: (2021-09-01)

RETRACTED ARTICLE: Content validity and psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with psoriatic arthritis
由: David Cella, et al.
出版: (2019-01-01)

Experience with tofacitinib in the treatment of resistant rheumatoid arthritis
由: A. R. Babaeva, et al.
出版: (2015-06-01)

Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis
由: S. Fromm, et al.
出版: (2019-12-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
由: Nikolay N. Murashkin, et al.
出版: (2020-12-01)

The Role of Structured Musculoskeletal Ultrasound in the Early Diagnosis of Rheumatoid Arthritis and Psoriatic Arthritis Patients: Correlation with Clinical Disease Activity Scores
由: Eman Abdel Ghani Sayed Mahmoud*
出版: (2024-07-01)